{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:33:17Z","timestamp":1778625197783,"version":"3.51.4"},"reference-count":56,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Cervical cancer is the fourth most frequent type of neoplasia in women. It is most commonly caused by the persistent infection with high-risk strands of human papillomavirus (hrHPV). Its incidence increases rapidly from age 25 when routine HPV screening starts and then decreases at the age of 45. This reflects both the diagnosis of prevalent cases at first-time screening and the likely peak of HPV exposure in early adulthood. For early stages, the treatment offers the possibility of fertility preservation.. However, in more advanced stages, the treatment is restricted to concomitant chemo-radiotherapy, combined, in very selected cases with surgical intervention. After the neoadjuvant treatment, an imagistic re-evaluation of the patients is carried out to analyze if the stage of the disease remained the same or suffered a downstaging. Lymph node downstaging following neoadjuvant treatment is regarded as an indubitable prognostic factor for predicting disease recurrence and survival in patients with advanced cervical cancer. This study aims to ascertain the important survival role of radiotherapy in the downstaging of the disease and of lymphadenectomy in the control of lymph node invasion for patients with advanced-stage cervical cancer. Material and Methods: We describe the outcome of patients with cervical cancer in stage IIIC1 FIGO treated at Bucharest Oncological Institute. All patients received radiotherapy and two-thirds received concomitant chemotherapy. A surgical intervention consisting of type C radical hysterectomy with radical pelvic lymphadenectomy was performed six to eight weeks after the end of the neoadjuvant treatment. Results: The McNemar test demonstrated the regression of lymphadenopathies after neoadjuvant treatment\u2014p: &lt;0.001. However, the persistence of adenopathies was not related to the dose of irradiation (p: 0.61), the number of sessions of radiotherapy (p: 0.80), or the chemotherapy (p: 0.44). Also, there were no significant differences between the adenopathies reported by imagistic methods and those identified during surgical intervention\u2014p: 0.62. The overall survival evaluated using Kaplan-Meier curves is dependent on the post-radiotherapy FIGO stage\u2014p: 0.002 and on the lymph node status evaluated during surgical intervention\u2014p: 0.04. The risk factors associated with an increased risk of death were represented by a low preoperative hemoglobin level (p: 0.003) and by the advanced FIGO stage determined during surgical intervention (p-value: 0.006 for stage IIIA and 0.01 for stage IIIC1). In the multivariate Cox model, the independent predictor of survival was the preoperative hemoglobin level (p: 0.004, HR 0.535, CI: 0.347 to 0.823). Out of a total of 33 patients with neoadjuvant treatment, 22 survived until the end of the study, all 33 responded to the treatment in varying degrees, but in 3 of them, tumor cells were found in the lymph nodes during the intraoperative histopathological examination. Conclusions: For advanced cervical cancer patients, radical surgery after neoadjuvant treatment may be associated with a better survival rate. Further research is needed to identify all the causes that lead to the persistence of adenopathies in certain patients, to decrease the FIGO stage after surgical intervention, and, therefore, to lower the risk of death. Also, it is mandatory to correctly evaluate and treat the anemia, as it seems to be an independent predictor factor for mortality.<\/jats:p>","DOI":"10.3390\/medicina60060871","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:14:07Z","timestamp":1716804847000},"page":"871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer"],"prefix":"10.3390","volume":"60","author":[{"given":"Irinel-Gabriel","family":"Dicu-Andreescu","sequence":"first","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian-Augustin","family":"Marinca\u0219","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-0199","authenticated-orcid":false,"given":"Anca-Angela","family":"Simionescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, 011171 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-5803","authenticated-orcid":false,"given":"Ioana","family":"Dicu-Andreescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-0651","authenticated-orcid":false,"given":"S\u00eenziana-Octavia","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-053X","authenticated-orcid":false,"given":"Virgiliu-Mihail","family":"Prunoiu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Br\u0103tucu","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren\u021biu","family":"Simion","sequence":"additional","affiliation":[{"name":"Clinical Department No 10, General Surgery, University of Medicine and Pharmacy \u201dCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"Department of Oncological Surgery, Oncological Institute \u201dProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human Papillomavirus and Cervical Cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"ref_3","first-page":"CD002834","article-title":"Interventions Targeted at Women to Encourage the Uptake of Cervical Screening","volume":"5","author":"Everett","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/hiv.13490","article-title":"The Recent Natural History of Human Papillomavirus Cervical Infection in Women Living with HIV: A Scoping Review of Meta-analyses and Systematic Reviews and the Construction of a Hypothetical Model","volume":"24","author":"Gilles","year":"2023","journal-title":"HIV Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Olusola, P., Banerjee, H.N., Philley, J.V., and Dasgupta, S. (2019). Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells, 8.","DOI":"10.3390\/cells8060622"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijgo.13870","article-title":"Obesity and Gynecological Cancers: A Toxic Relationship","volume":"155","author":"Wichmann","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a Major Risk Factor for Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_8","first-page":"17455065221075904","article-title":"High Parity Is Associated with Increased Risk of Cervical Cancer: Systematic Review and Meta-Analysis of Case-Control Studies","volume":"18","author":"Tekalegn","year":"2022","journal-title":"Womens Health"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Dicu-Andreescu, I.-G., Marinca\u0219, M.-A., Prunoiu, V.-M., Dicu-Andreescu, I., Ionescu, S.-O., Simionescu, A.-A., Br\u0103tucu, E., and Simion, L. (2023). The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer. Medicina, 59.","DOI":"10.3390\/medicina59122147"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical Cancer Control in HIV-Infected Women: Past, Present and Future","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.12968\/bjon.2015.24.Sup10.S22","article-title":"Prevention and Early Detection of Cervical Cancer in the UK","volume":"24","author":"Foran","year":"2015","journal-title":"Br. J. Nurs."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1200\/JCO.21.01930","article-title":"Human Papillomavirus Infection Determines Prognosis in Cervical Cancer","volume":"40","author":"Lei","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_13","unstructured":"(2024, February 15). Cervical Cancer Statistics by Age. Available online: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer\/incidence#heading-One."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical Cancer in Low and Middle-income Countries (Review)","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_15","unstructured":"(2023, June 18). NCCN Guidelines for Cervical Cancer. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the Management of Patients with Cervical Cancer\u2014Update 2023*","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1167088","DOI":"10.3389\/fonc.2023.1167088","article-title":"Editorial: Methods in Gynecological Oncology","volume":"13","author":"Perelli","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"\u00c1yen, \u00c1., Jim\u00e9nez Mart\u00ednez, Y., and Boulaiz, H. (2020). Targeted Gene Delivery Therapies for Cervical Cancer. Cancers, 12.","DOI":"10.3390\/cancers12051301"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2013.09.004","article-title":"Management of Low-Risk Early-Stage Cervical Cancer: Should Conization, Simple Trachelectomy, or Simple Hysterectomy Replace Radical Surgery as the New Standard of Care?","volume":"132","author":"Ramirez","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","article-title":"2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy","volume":"24","author":"Querleu","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dicu-Andreescu, I.-G., Marinca\u0219, A.-M., Ungureanu, V.-G., Ionescu, S.-O., Prunoiu, V.-M., Br\u0103tucu, E., and Simion, L. (2023). Current Therapeutic Approaches in Cervical Cancer Based on the Stage of the Disease: Is There Room for Improvement?. Medicina, 59.","DOI":"10.3390\/medicina59071229"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(08)70074-3","article-title":"Classification of Radical Hysterectomy","volume":"9","author":"Querleu","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ijgc-00009577-200311000-00030","article-title":"Laterally Extended Parametrectomy (LEP), the Technique for Radical Pelvic Side Wall Dissection: Feasibility, Technique and Results","volume":"13","author":"Palfalvi","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","unstructured":"Nagy, V., Rancea, A., Coza, O., Kacso, G., and Aldea, B. (2024, March 04). Alexandru Eniu Ghid MS Conduita Cancer Col Uterin. Available online: http:\/\/old.ms.ro\/index.php?pag=181&pg=5."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527712","article-title":"Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA\u2013IIA Cervical Cancer","volume":"88","author":"Cao","year":"2023","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2021.06.002","article-title":"The Role of Semiquantitative Evaluation of Lympho-Vascular Space Invasion in Early Stage Cervical Cancer Patients","volume":"162","author":"Ronsini","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_28","first-page":"700","article-title":"Diagnostic Value and Clinical Significance of MRI and CT in Detecting Lymph Node Metastasis of Early Cervical Cancer","volume":"19","author":"Luo","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_29","first-page":"10536","article-title":"CT, MRI, and PET Imaging Features in Cervical Cancer Staging and Lymph Node Metastasis","volume":"13","author":"Zhu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3802\/jgo.2022.33.e14","article-title":"Comparison of Treatment Outcomes of Surgery and Radiotherapy, Including Concurrent Chemoradiotherapy for Stage Ib2-IIb Cervical Adenocarcinoma Patients: A Retrospective Study","volume":"33","author":"Kondo","year":"2022","journal-title":"J. Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/etm.2020.9525","article-title":"Impact of Histological Subtype on the Response to Chemoradiation in Locally Advanced Cervical Cancer and the Possible Role of Surgery","volume":"21","author":"Voinea","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3892\/ol.2015.3105","article-title":"Response of Adenocarcinoma of the Uterine Cervix to Chemoradiotherapy","volume":"9","author":"Yosefia","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kang, J.-H., Cho, W.K., Yeo, H.J., Jeong, S.Y., Noh, J.J., Shim, J.I., Lee, Y.-Y., Kim, T.-J., Lee, J.-W., and Kim, B.-G. (2020). Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113471"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jrr\/rrt097","article-title":"Impact of Boost Irradiation on Pelvic Lymph Node Control in Patients with Cervical Cancer","volume":"55","author":"Wakatsuki","year":"2014","journal-title":"J. Radiat. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/02841860600833160","article-title":"Clinical Relevance of Hemoglobin Level in Cervical Cancer Patients Administered Definitive Radiotherapy","volume":"45","author":"Serkies","year":"2006","journal-title":"Acta Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/ctrv.2000.0181","article-title":"Anaemia in Cancer: Pathophysiology and Treatment","volume":"26","author":"Mercadante","year":"2000","journal-title":"Cancer Treat. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0360-3016(03)00123-8","article-title":"Anemia in Cervical Cancers: Impact on Survival, Patterns of Relapse, and Association with Hypoxia and Angiogenesis","volume":"56","author":"Dunst","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an Independent Prognostic Factor for Survival in Patients with Cancer: A Systemic, Quantitative Review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"940807","DOI":"10.3389\/fonc.2022.940807","article-title":"Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e000462","DOI":"10.1136\/esmoopen-2018-000462","article-title":"Targeted Therapy in Cervical Cancer","volume":"3","author":"Vora","year":"2018","journal-title":"ESMO Open"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Watkins, D.E., Craig, D.J., Vellani, S.D., Hegazi, A., Fredrickson, K.J., Walter, A., Stanbery, L., and Nemunaitis, J. (2023). Advances in Targeted Therapy for the Treatment of Cervical Cancer. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185992"},{"key":"ref_43","first-page":"4649","article-title":"Factors Associated with Radiosensitivity of Cervical Cancer","volume":"34","author":"Qin","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4103\/jcrt.JCRT_1028_17","article-title":"Factors Affecting Quality of Life of Cervical Cancer Patients: A Multivariate Analysis","volume":"15","author":"Singh","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2014.08.036","article-title":"Factors Associated with Poor Quality of Life among Cervical Cancer Survivors: Implications for Clinical Care and Clinical Trials","volume":"135","author":"Osann","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mereu, L., Pecorino, B., Ferrara, M., Tomaselli, V., Scibilia, G., and Scollo, P. (2023). Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: Retrospective Single-Center Study. Cancers, 15.","DOI":"10.3390\/cancers15215207"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e30745","DOI":"10.1097\/MD.0000000000030745","article-title":"Prognostic Value of Lymph Node Ratio in Cervical Cancer: A Meta-Analysis","volume":"101","author":"Cui","year":"2022","journal-title":"Medicine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"934110","DOI":"10.3389\/fonc.2022.934110","article-title":"The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3389\/fonc.2019.01106","article-title":"Score for the Overall Survival Probability of Patients With First-Diagnosed Distantly Metastatic Cervical Cancer: A Novel Nomogram-Based Risk Assessment System","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0090-8258(84)90151-3","article-title":"Survival and Patterns of Recurrence in Cervical Cancer Metastatic to Periaortic Lymph Nodes","volume":"19","author":"Berman","year":"1984","journal-title":"Gynecol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1200\/JCO.2022.40.16_suppl.5531","article-title":"Staging Locally Advanced Cervical Cancer with FIGO 2018 versus FIGO 2008: Impact on Overall Survival and Progression-Free Survival in the OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)","volume":"40","author":"Mileshkin","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ronsini, C., De Franciscis, P., Carotenuto, R.M., Pasanisi, F., Cobellis, L., and Colacurci, N. (2022). The Oncological Implication of Sentinel Lymph Node in Early Cervical Cancer: A Meta-Analysis of Oncological Outcomes and Type of Recurrences. Medicina, 58.","DOI":"10.3390\/medicina58111539"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2022.04.010","article-title":"Laparo-Assisted Vaginal Radical Hysterectomy as a Safe Option for Minimal Invasive Surgery in Early Stage Cervical Cancer: A Systematic Review and Meta-Analysis","volume":"166","author":"Ronsini","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1245\/s10434-023-13542-z","article-title":"Fertility-Sparing Treatment for Early-Stage Cervical Cancer \u2265 2 Cm: Can One Still Effectively Become a Mother? A Systematic Review of Fertility Outcomes","volume":"30","author":"Ronsini","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1245\/s10434-022-12436-w","article-title":"Fertility-Sparing Treatment for Early-Stage Cervical Cancer \u2265 2 Cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes","volume":"29","author":"Ronsini","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_56","first-page":"111","article-title":"Urodynamic Changes in Urethrovesical Function After Radical Hysterectomy","volume":"68","author":"Scotti","year":"1986","journal-title":"Obstet. Gynecol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:49:07Z","timestamp":1760107747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,26]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["medicina60060871"],"URL":"https:\/\/doi.org\/10.3390\/medicina60060871","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,26]]}}}